[
    [
        {
            "time": "",
            "original_text": "5轮融资后冲刺科创板尚未问询回复，博瑞制药或成为“难产王”？",
            "features": {
                "keywords": [
                    "融资",
                    "科创板",
                    "问询回复",
                    "博瑞制药",
                    "难产"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "5轮融资后冲刺科创板尚未问询回复，博瑞制药或成为“难产王”？",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]